Kestra Advisory Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$713K	Sell	1,362 -218	-14%	-$104K	﹤0.01%	1964
2025 Q4	$920K	Buy	1,580 +13	+0.8%	+$6.64K	﹤0.01%	1714
2025 Q3	$719K	Sell	1,567 -98	-6%	-$36.6K	﹤0.01%	1821
2025 Q2	$504K	Sell	1,665 -41	-2%	-$12.2K	﹤0.01%	1958
2025 Q1	$565K	Buy	1,706 +1	+0.1%	+$329	﹤0.01%	1740
2024 Q4	$526K	Sell	1,705 -909	-35%	-$256K	﹤0.01%	1842
2024 Q3	$555K	Buy	2,614 +145	+6%	+$37.1K	﹤0.01%	1707
2024 Q2	$692K	Sell	2,469 -115	-4%	-$27.4K	﹤0.01%	1559
2024 Q1	$690K	Sell	2,584 -1,020	-28%	-$240K	﹤0.01%	1463
2023 Q4	$834K	Sell	3,604 -2	-0.1%	-$350	0.01%	1220
2023 Q3	$527K	Buy	3,606 +25	+0.7%	+$4.71K	0.01%	1344
2023 Q2	$827K	Buy	3,581 +1,021	+40%	+$277K	0.01%	1069
2023 Q1	$620K	Buy	2,560 +104	+4%	+$28.3K	0.01%	1169
2022 Q4	$713K	Buy	+2,456	New	+$240K	0.01%	1212